Fig. 2
From: EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
EZH2 expression was positively correlated with galctin-9 expression in HCC cells. a Knocking down EZH2 decreased basal galectin-9 expression at the protein and mRNA levels in HepG2 and Hep3B cells. b EZH2 overexpression increased galectin-9 expression at the protein and mRNA levels in HepG2 and Hep3B cells. c Knocking down EZH2 abolished IFN-γ-induced galectin-9 expression in HepG2 and Hep3B cells. (* P < 0.05, **P < 0.01, compared to control or vector group)